AVITA Medical (RCEL) Assets Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.25% |
| Sep 30, 2025 | -21.37% |
| Jun 30, 2025 | -33.81% |
| Mar 31, 2025 | -28.57% |
| Dec 31, 2024 | -28.60% |
| Sep 30, 2024 | 0.05% |
| Jun 30, 2024 | 1.73% |
| Mar 31, 2024 | 5.14% |
| Dec 31, 2023 | 13.61% |
| Sep 30, 2023 | -18.93% |
| Jun 30, 2023 | -15.91% |
| Mar 31, 2023 | -13.02% |
| Dec 31, 2022 | -15.30% |
| Sep 30, 2022 | -17.53% |
| Jun 30, 2022 | -18.19% |
| Mar 31, 2022 | -16.86% |
| Dec 31, 2021 | 67.40% |
| Sep 30, 2021 | 60.67% |
| Jun 30, 2021 | 52.19% |
| Dec 31, 2020 | -25.45% |
| Jun 30, 2020 | 220.44% |
| Jun 30, 2019 | 47.69% |